EFFECT ·Filed Mar 2, 2026
IPO/offering going effective
Actionable Insight • Neutral
Monitor for future prospectus supplements that will disclose actual offering terms, timing, and size. Shelf registrations allow flexibility but create potential dilution overhang.
Final — all horizons settled through T+60d
SYRE ▲ +73.33% at T+60d
NEUTRAL call ✓ call won +73.33% · α vs SPY +64.01% · entry $42.49 → $73.65
T+1d
-5.70%
call -5.70% · α -4.78%
$40.07
settled 7mo ago
T+5d
-3.34%
call -3.34% · α -2.13%
$41.07
settled 7mo ago
T+20d
+6.90%
call +6.90% · α +14.83%
$45.42
settled 6mo ago
T+60d
+73.33%
call +73.33% · α +64.01%
$73.65
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Spyre Therapeutics' shelf registration (Form S-3) has become effective, allowing the company to issue unspecified securities from time to time. This is a routine capital markets update with no immediate financial impact.
Key Facts
- Form EFFECT filed for Spyre Therapeutics, Inc. (SYRE)
- Effectiveness date: February 27, 2026
- Underlying registration is Form S-3 (shelf registration)
- No specific offering size, pricing, or securities type disclosed
- Company previously known as Aeglea BioTherapeutics, Inc.
Financial Impact
Not specified
dilutioncapital_structure
Risk Factors
- Future issuance could lead to shareholder dilution
- Market perception of equity overhang may pressure stock price
Market Snapshot
Exchange
Nasdaq
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-000695 |
| Document: 9999999995-26-000695-index.html | 9999999995-26-000695 |
| Document: 9999999995-26-000695.txt | 9999999995-26-000695 |
26 reports for SYRE
77% Hit rate best @ T+60▲ +54.27%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | Insider Cluster | $88.98 $90.80 | ▼ −2.05% | ▼ −3.25% | $93.19 (−4.73%) |
Aug 11, 2026 7w ago | Insider Cluster | $102.74 $107.82 | ▼ −4.94% | ▼ −5.35% | $93.19 (+9.30%) |
Aug 6, 2026 8w ago | Insider Cluster | $103.42 $101.85 | ▲ +1.52% | ▲ +2.73% | $93.19 (+9.89%) |
Jul 3, 2026 13w ago | Insider Cluster | $86.63 $98.75 | ▲ +13.99% | ▲ +13.06% | $93.19 (+7.57%) |
Jun 27, 2026 13w ago | Insider Cluster | $90.16 $88.74 | ▲ +1.57% | ▲ +2.96% | $93.19 (−3.36%) |
Jun 26, 2026 14w ago | S-3ASR | $90.16 $88.74 | ▼ −1.57% | ▼ −2.96% | $93.19 (+3.36%) |
Jun 24, 2026 14w ago | Insider Cluster | $86.24 $88.89 | ▼ −3.07% | ▼ −1.37% | $93.19 (−8.06%) |
Jun 15, 2026 15w ago | 8-K | $83.58 $100.32 | ▲ +20.03% | ▲ +21.41% | $93.19 (+11.50%) |
Jun 12, 2026 16w ago | Institutional Cluster | $80.79 $88.34 | ▲ +9.35% | ▲ +8.67% | $93.19 (+15.35%) |
Jun 11, 2026 16w ago | Institutional Cluster | $80.77 $87.49 | ▲ +8.32% | ▲ +7.89% | $93.19 (+15.38%) |
Showing 10 of 26
US Market Status
Market Closed — Opens Mon (65h 6m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access